simvastatin has been researched along with Chemical and Drug Induced Liver Injury in 58 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 8 (13.79) | 18.2507 |
2000's | 14 (24.14) | 29.6817 |
2010's | 29 (50.00) | 24.3611 |
2020's | 7 (12.07) | 2.80 |
Authors | Studies |
---|---|
Ahmad, S; Barrish, JC; Bird, E; Bisaha, S; Blanar, MA; Chang, M; Chen, BC; Chen, X; Cuff, CA; Darienzo, CJ; Giancarli, M; Harrity, T; Huang, C; Janovitz, E; Kennedy, LJ; Li, T; Madsen, CS; Monshizadegan, H; Ngu, K; Nguyen-Tran, V; Reeves, RA; Robl, JA; Ryan, CS; Search, D; Setters, R; Sitkoff, D; Stein, PD; Yin, X; Zahler, R; Zhang, R; Zhao, R; Zhuang, S | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Ding, D; Fang, H; Kelly, R; Liu, Z; Shi, Q; Tong, W | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Aleo, MD; Bonin, PD; Luo, Y; Potter, DM; Swiss, R; Will, Y | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Abd El Reheem, MH; Ahmed, SA; Elbahy, DA | 1 |
Li, XY; Mao, YM; Zhong, W | 1 |
Armas Flórez, CD; Concepción-Zavaleta, MJ; Gonzáles Yovera, JG; Moreno Marreros, DM | 1 |
Carubbi, F; Nascimbeni, F; Onfiani, G | 1 |
Albrahim, T; Alonazi, MA | 1 |
Abdelsalam, RM; Abo-Zalam, HB; El-Denshary, ES; Hamzawy, MA; Khalil, IA; Khattab, MM | 1 |
Alanazi, NS; Alenazi, TS; Alenzi, KA | 1 |
Duan, F; Guo, Z; Liu, Y; Xian, Z; Xiao, H; Xu, W | 1 |
Cui, R; Feng, Y; Liang, H; Liu, C; Qiu, M; Zhang, J | 1 |
Aschmann, HE; Kaufmann, M; Puhan, MA; Yebyo, HG | 1 |
Mikiewicz, M; Otrocka-Domagała, I; Paździor-Czapula, K | 1 |
Ahmed, EA; Ali, MF; Hareedy, MS | 1 |
El-Boghdady, NA; Ibrahim, SA; Motawi, TK; Teleb, ZA | 1 |
Also, MA; Bastida, C; Letang, E; Miró, JM; Pericas, JM; Tuset, M | 1 |
Peña-Irún, Á | 1 |
Majeed, A; Muneera, KE; Naveed, AK | 1 |
Beck-Peccoz, P; Campi, I; Covelli, D; Currò, N; D'Ambrosio, R; Gianelli, U; Maggioni, M; Salvi, M; Vannucchi, G | 1 |
Lopez, JL; Tayek, JA | 1 |
Fang, RF; Gao, SQ; Li, JH; Pan, YT; Zhan, SY; Zhang, J | 1 |
Björnsson, ES | 1 |
Daly, AK | 2 |
Björnsson, E; Jacobsen, EI; Kalaitzakis, E | 1 |
Bing, N; de Souza, PL; Goodman, VL; King, KS; McCann, LA; Mooser, VE; Pandite, LN; Spraggs, CF; Xu, CF; Xue, Z | 1 |
Abraldes, JG; Bosch, J; García-Pagán, JC; Gracia-Sancho, J; Hide, D; La Mura, V; Meireles, CZ; Miquel, R; Pasarín, M; Rodríguez-Vilarrupla, A | 1 |
Itakura, H; Kita, T; Mabuchi, H; Matsuzaki, M; Matsuzawa, Y; Nakaya, N; Oikawa, S; Saito, Y; Sasaki, J; Shimamoto, K | 1 |
Ashar, U; Bhaduri, A; Desai, D | 1 |
Blazing, M; Braunwald, E; Califf, R; Cannon, CP; de Lemos, JA; McCabe, CH; Murphy, SA; Wiviott, SD | 1 |
Guirguis, A; Ricaurte, B; Taylor, HC; Zabriskie, D | 1 |
Guthrie, RM | 1 |
Alican, I; Ercan, F; Gedik, N; Işeri, S; Yüksel, M | 1 |
Alsheikh-Ali, AA; Karas, RH | 1 |
Arkad'eva, AV; Baĭdiuk, EV; Morozov, VI; Okovityĭ, SV; Sakuta, GA; Shiriaeva, AP | 1 |
Alsheikh-Ali, AA; Han, H; Karas, RH; Maddukuri, PV | 1 |
Chudy, B; Lata, S | 1 |
Fehmers, MC; Koornstra, JJ; Ottervanger, JP; Stricker, BH | 1 |
Lee, TH | 1 |
Bataille, L; Hamoir, V; Horsmans, Y; Nakad, A; Sempoux, C | 1 |
Gabbert, HE; Gerards, H; Heuer, T; Pauw, M; Reis, HE | 1 |
Caldwell, SH; Hespenheide, EE; von Borstel, RW | 1 |
Byrd, RP; Fields, CL; Kanathur, N; Mathai, MG; Roy, TM | 1 |
Baziz, A; Becot, F; Piquemal, A; Roblin, X | 1 |
Walker, JF | 1 |
Ballaré, M; Bordin, G; Campanini, M; Catania, E; Monteverde, A; Zaccala, G | 1 |
Bogomoletz, WV; Feydy, P | 1 |
8 review(s) available for simvastatin and Chemical and Drug Induced Liver Injury
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Comparative effectiveness and safety of statins as a class and of specific statins for primary prevention of cardiovascular disease: A systematic review, meta-analysis, and network meta-analysis of randomized trials with 94,283 participants.
Topics: Atorvastatin; Cardiovascular Diseases; Cause of Death; Chemical and Drug Induced Liver Injury; Double-Blind Method; Fluvastatin; Headache; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Diseases; Lovastatin; Middle Aged; Muscular Diseases; Nausea; Neoplasms; Network Meta-Analysis; Placebos; Pravastatin; Randomized Controlled Trials as Topic; Risk Assessment; Rosuvastatin Calcium; Simvastatin; Withholding Treatment | 2019 |
Voriconazole-Induced Hepatitis via Simvastatin- and Lansoprazole-Mediated Drug Interactions: A Case Report and Review of the Literature.
Topics: Adult; Antifungal Agents; Biotransformation; Chemical and Drug Induced Liver Injury; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Dyslipidemias; Gastroesophageal Reflux; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Jaundice, Obstructive; Lansoprazole; Liver; Male; Polypharmacy; Proton Pump Inhibitors; Pulmonary Aspergillosis; Simvastatin; Voriconazole | 2016 |
Hepatotoxicity of statins and other lipid-lowering agents.
Topics: Atorvastatin; Chemical and Drug Induced Liver Injury; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Simvastatin | 2017 |
Genome-wide association studies in pharmacogenomics.
Topics: Anticoagulants; Aryl Hydrocarbon Hydroxylases; Chemical and Drug Induced Liver Injury; Cytochrome P-450 CYP2C9; Drug-Related Side Effects and Adverse Reactions; Floxacillin; Genome-Wide Association Study; Humans; Interferon-alpha; Mixed Function Oxygenases; Muscular Diseases; Pharmacogenetics; Platelet Aggregation Inhibitors; Simvastatin; Vitamin K Epoxide Reductases | 2010 |
Using genome-wide association studies to identify genes important in serious adverse drug reactions.
Topics: Aryl Hydrocarbon Hydroxylases; Carbamazepine; Chemical and Drug Induced Liver Injury; Cytochrome P-450 CYP2C8; Drug-Related Side Effects and Adverse Reactions; Exanthema; Genetic Predisposition to Disease; Genome-Wide Association Study; Genome, Human; Genotype; HLA-A Antigens; Humans; Hypersensitivity; Liver; Pharmacogenetics; Polymorphism, Genetic; Risk Factors; Simvastatin | 2012 |
How safe is aggressive statin therapy?
Topics: Atorvastatin; Chemical and Drug Induced Liver Injury; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Muscular Diseases; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Simvastatin; Sulfonamides | 2006 |
Effect of the magnitude of lipid lowering on risk of elevated liver enzymes, rhabdomyolysis, and cancer: insights from large randomized statin trials.
Topics: Chemical and Drug Induced Liver Injury; Cholesterol, LDL; Dose-Response Relationship, Drug; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Indoles; Liver Diseases; Lovastatin; Neoplasms; Pravastatin; Rhabdomyolysis; Simvastatin | 2007 |
3 trial(s) available for simvastatin and Chemical and Drug Induced Liver Injury
Article | Year |
---|---|
Influence of simvastatin on hepatocytes - histopathological and immunohistochemical study.
Topics: Animals; Chemical and Drug Induced Liver Injury; Female; Hepatocytes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunohistochemistry; Random Allocation; Simvastatin; Swine; Swine Diseases | 2019 |
HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment.
Topics: Arterial Occlusive Diseases; Chemical and Drug Induced Liver Injury; Death, Sudden, Cardiac; Delayed-Action Preparations; Drug Therapy, Combination; Female; Humans; Hypolipidemic Agents; Indoles; Male; Middle Aged; Muscular Diseases; Myocardial Infarction; Myocardial Reperfusion; Niacin; Simvastatin; Stroke | 2013 |
Worldwide experience with simvastatin/lovastatin.
Topics: Anticholesteremic Agents; Chemical and Drug Induced Liver Injury; Cholesterol, LDL; Coronary Artery Disease; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Long-Term Care; Lovastatin; Rhabdomyolysis; Simvastatin | 1992 |
47 other study(ies) available for simvastatin and Chemical and Drug Induced Liver Injury
Article | Year |
---|---|
(3R,5S,E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(methyl(1-methyl-1h-1,2,4-triazol-5-yl)amino)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoic acid (BMS-644950): a rationally designed orally efficacious 3-hydroxy-3-methylglutaryl coenzyme-a reductase inhibitor with
Topics: Administration, Oral; Animals; Biological Availability; Chemical and Drug Induced Liver Injury; Cholesterol; Crystallography, X-Ray; Dogs; Female; Guinea Pigs; Haplorhini; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Liver; Models, Molecular; Muscle Cells; Pyrimidines; Rats; Rats, Sprague-Dawley; Stereoisomerism; Structure-Activity Relationship; Triazoles | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Models, Biological; Predictive Value of Tests | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Human drug-induced liver injury severity is highly associated with dual inhibition of liver mitochondrial function and bile salt export pump.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Chemical and Drug Induced Liver Injury; Humans; Male; Mitochondria, Liver; Rats; Rats, Sprague-Dawley; Severity of Illness Index | 2014 |
l-Carnitine ameliorates the osteoporotic changes and protects against simvastatin induced myotoxicity and hepatotoxicity in glucocorticoid-induced osteoporosis in rats.
Topics: Animals; Carnitine; Chemical and Drug Induced Liver Injury; Glucocorticoids; Myotoxicity; Osteoporosis; Rats; Rats, Wistar; Simvastatin | 2022 |
[Statin-related drug-induced liver injury].
Topics: Atorvastatin; Chemical and Drug Induced Liver Injury; Drug-Related Side Effects and Adverse Reactions; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Simvastatin | 2023 |
Statins in liver cirrhosis in a developing country: benefits overweigh the risk?
Topics: Chemical and Drug Induced Liver Injury; Contraindications, Drug; Developing Countries; Hepatitis, Viral, Human; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Liver Cirrhosis; Meta-Analysis as Topic; Non-alcoholic Fatty Liver Disease; Obesity; Peru; Risk Assessment; Simvastatin | 2020 |
A case of statin-induced liver injury with positive rechallenge with a second statin. Is there a class effect?
Topics: Chemical and Drug Induced Liver Injury; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Middle Aged; Simvastatin | 2021 |
Lycopene corrects metabolic syndrome and liver injury induced by high fat diet in obese rats through antioxidant, anti-inflammatory, antifibrotic pathways.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Blood Glucose; Chemical and Drug Induced Liver Injury; Cytokines; Diet, High-Fat; Fibrinolytic Agents; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Insulin; Lipid Metabolism; Lipids; Liver Cirrhosis; Lycopene; Male; Metabolic Syndrome; Obesity; Rats; Rats, Wistar; Simvastatin; Weight Gain | 2021 |
Therapeutic advancement of simvastatin-loaded solid lipid nanoparticles (SV-SLNs) in treatment of hyperlipidemia and attenuating hepatotoxicity, myopathy and apoptosis: Comprehensive study.
Topics: Animals; Apoptosis; Biological Availability; Chemical and Drug Induced Liver Injury; Drug Carriers; Drug Delivery Systems; Hyperlipidemias; Lipids; Male; Muscular Diseases; Nanoparticles; Particle Size; Rats; Rats, Wistar; Simvastatin | 2021 |
Hepatotoxicity Induced by Fluvastatin: A Reversible Acute Cholestatic Liver Injury.
Topics: Aged; Chemical and Drug Induced Liver Injury; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Simvastatin | 2021 |
The Anti-hyperlipidemia Effects of Raw Polygonum multiflorum Extract in Vivo.
Topics: Acetyl-CoA Carboxylase; Administration, Oral; Animals; Chemical and Drug Induced Liver Injury; Cholesterol, LDL; Diet, High-Fat; Disease Models, Animal; Drugs, Chinese Herbal; Fallopia multiflora; Fatty Acid Synthase, Type I; Hepatocytes; Humans; Hydroxymethylglutaryl CoA Reductases; Hyperlipidemias; Hypolipidemic Agents; Lipid Metabolism; Liver; Male; Medicine, Chinese Traditional; Rats, Sprague-Dawley; Simvastatin; Triglycerides | 2017 |
Simvastatin protects against acetaminophen-induced liver injury in mice.
Topics: Acetaminophen; Alanine Transaminase; Animals; Antioxidants; Apoptosis; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Glutathione; Liver; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Oxidative Stress; Protective Agents; Simvastatin; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2018 |
Montelukast modifies simvastatin-induced myopathy and hepatotoxicity.
Topics: Acetates; Albumins; Animals; Bilirubin; Chemical and Drug Induced Liver Injury; Creatine Kinase; Cyclopropanes; Drug Interactions; Globulins; Liver Function Tests; Male; Muscular Diseases; Myoglobin; Quinolines; Rats; Simvastatin; Sulfides | 2019 |
Effect of simvastatin and naringenin coadministration on rat liver DNA fragmentation and cytochrome P450 activity: an in vivo and in vitro study.
Topics: Alanine Transaminase; Animals; Anticholesteremic Agents; Antioxidants; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Cytochrome P-450 CYP2E1; Cytochrome P-450 CYP3A; DNA Fragmentation; Drug Evaluation, Preclinical; Drug Interactions; Female; Flavanones; Glutathione; Liver; Malondialdehyde; Microsomes, Liver; Rats; Rats, Wistar; Simvastatin; Superoxide Dismutase | 2014 |
[Rhabdomyolysis and severe hepatotoxicity due to a drug-drug interaction between ritonavir and simvastatin. Could we use the most cost-effective statin in all human immunodeficiency virus-infected patients?].
Topics: Antiretroviral Therapy, Highly Active; Atorvastatin; Chemical and Drug Induced Liver Injury; Comorbidity; Contraindications; Cost-Benefit Analysis; Cytochrome P-450 CYP3A Inhibitors; Drug Substitution; Drug Synergism; Dyslipidemias; Female; HIV Infections; HIV Protease Inhibitors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Tubular Necrosis, Acute; Middle Aged; Rhabdomyolysis; Ritonavir; Simvastatin | 2014 |
[Drug-induced liver injury caused by simvastatin associated with antinuclear antibodies].
Topics: Aged; Antibodies, Antinuclear; Chemical and Drug Induced Liver Injury; Female; Hepatitis, Autoimmune; Humans; Hypolipidemic Agents; Simvastatin | 2015 |
Comparative evaluation of Nigella sativa (Kalonji) and simvastatin for the treatment of hyperlipidemia and in the induction of hepatotoxicity.
Topics: Alanine Transaminase; Animals; Chemical and Drug Induced Liver Injury; Cholesterol; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Nigella sativa; Phytotherapy; Rats; Rats, Sprague-Dawley; Simvastatin; Triglycerides | 2015 |
Statins may increase the risk of liver dysfunction in patients treated with steroids for active graves' orbitopathy.
Topics: Chemical and Drug Induced Liver Injury; Female; Glucocorticoids; Graves Ophthalmopathy; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Methylprednisolone; Middle Aged; Simvastatin | 2015 |
[Association between statins use and liver injury based on prescription sequence symmetry analysis].
Topics: Atorvastatin; Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver; Prescription Drugs; Simvastatin | 2016 |
Hepatotoxicity associated with statins: reports of idiosyncratic liver injury post-marketing.
Topics: Adverse Drug Reaction Reporting Systems; Aged; Atorvastatin; Chemical and Drug Induced Liver Injury; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pyrroles; Simvastatin; Sweden; Time Factors | 2012 |
Concomitant use of pazopanib and simvastatin increases the risk of transaminase elevations in patients with cancer.
Topics: Alanine Transaminase; Anticholesteremic Agents; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Drug Interactions; Humans; Hypercholesterolemia; Incidence; Indazoles; Neoplasm Proteins; Neoplasms; Polymorphism, Single Nucleotide; Pyrimidines; Reference Values; Simvastatin; Sulfonamides | 2012 |
Effects of simvastatin administration on rodents with lipopolysaccharide-induced liver microvascular dysfunction.
Topics: Animals; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Endothelium, Vascular; Endotoxemia; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipopolysaccharides; Liver; Liver Circulation; Male; Microcirculation; Rats; Rats, Wistar; Simvastatin; Vascular Resistance | 2013 |
Sustained reduction of serum cholesterol in low-dose 6-year simvastatin treatment with minimum side effects in 51,321 Japanese hypercholesterolemic patients.
Topics: Anticholesteremic Agents; Chemical and Drug Induced Liver Injury; Cholesterol; Cohort Studies; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Hypercholesterolemia; Male; Middle Aged; Musculoskeletal Diseases; Osmolar Concentration; Simvastatin | 2003 |
Flutamide-induced hepatotoxicity with possible potentiation by simvastatin.
Topics: Aged; Chemical and Drug Induced Liver Injury; Drug Synergism; Flutamide; Humans; Male; Prostatic Neoplasms; Simvastatin | 2003 |
A tale of two trials: a comparison of the post-acute coronary syndrome lipid-lowering trials A to Z and PROVE IT-TIMI 22.
Topics: Aged; Angina, Unstable; Atorvastatin; C-Reactive Protein; Cardiovascular Diseases; Case Management; Chemical and Drug Induced Liver Injury; Comorbidity; Confounding Factors, Epidemiologic; Dose-Response Relationship, Drug; Endpoint Determination; Female; Heptanoic Acids; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Life Tables; Lipids; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Myocardial Ischemia; Myocardial Revascularization; Pravastatin; Pyrroles; Randomized Controlled Trials as Topic; Research Design; Risk; Risk Factors; Simvastatin; Stroke; Tirofiban; Treatment Outcome; Tyrosine | 2006 |
Simvastatin-amiodarone interaction resulting in rhabdomyolysis, azotemia, and possible hepatotoxicity.
Topics: Aged; Amiodarone; Chemical and Drug Induced Liver Injury; Drug Interactions; Humans; Male; Rhabdomyolysis; Simvastatin; Treatment Outcome; Uremia | 2006 |
Simvastatin attenuates cisplatin-induced kidney and liver damage in rats.
Topics: Alanine Transaminase; Animals; Antineoplastic Agents; Aspartate Aminotransferases; Bilirubin; Blood Urea Nitrogen; Chemical and Drug Induced Liver Injury; Cisplatin; Creatinine; Female; Glutathione; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Diseases; L-Lactate Dehydrogenase; Liver Diseases; Male; Malondialdehyde; Peroxidase; Rats; Rats, Sprague-Dawley; Serum Albumin; Simvastatin | 2007 |
Safety of lovastatin/extended release niacin compared with lovastatin alone, atorvastatin alone, pravastatin alone, and simvastatin alone (from the United States Food and Drug Administration adverse event reporting system).
Topics: Adverse Drug Reaction Reporting Systems; Atorvastatin; Chemical and Drug Induced Liver Injury; Drug Prescriptions; Drug Therapy, Combination; Dyslipidemias; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Liver Diseases; Lovastatin; Niacin; Pravastatin; Prevalence; Pyrroles; Retrospective Studies; Rhabdomyolysis; Risk Factors; Simvastatin; United States; United States Food and Drug Administration | 2007 |
[Hepatocyte mitochondrion respiratory chain in rats with experimental toxic hepatitis].
Topics: Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Cytochromes c; Dinitrophenols; Electron Transport; Ethanol; Hepatocytes; Malates; Male; Mitochondria; Oxygen Consumption; Pyruvic Acid; Rats; Rats, Wistar; Rotenone; Simvastatin | 2007 |
[Acute cholestatic hepatitis caused by simvastatine in a 67-year-old patient].
Topics: Acute Disease; Aged; Chemical and Drug Induced Liver Injury; Cholestasis, Intrahepatic; Humans; Hyperbilirubinemia; Jaundice, Obstructive; Male; Prednisone; Pruritus; Simvastatin; Treatment Outcome | 2006 |
[Clinically manifest liver lesions during use of simvastatin].
Topics: Aged; Anticholesteremic Agents; Chemical and Drug Induced Liver Injury; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Jaundice; Lovastatin; Male; Middle Aged; Simvastatin | 1996 |
I take Zocor for high cholesterol. My doctor checks my lipid levels every six months and they have been pretty good for a few years now. But he also checks my liver-function tests, because liver damage is one of the side effects of this drug. How worried
Topics: Anticholesteremic Agents; Chemical and Drug Induced Liver Injury; Humans; Liver Diseases; Liver Function Tests; Simvastatin | 1998 |
Atorvastatin-induced acute hepatitis with absence of cross-toxicity with simvastatin.
Topics: Aged; Anticholesteremic Agents; Atorvastatin; Chemical and Drug Induced Liver Injury; Drug Interactions; Female; Heptanoic Acids; Humans; Hypercholesterolemia; Pyrroles; Simvastatin | 1999 |
[Toxic liver damage caused by HMG-CoA reductase inhibitor].
Topics: Aged; Chemical and Drug Induced Liver Injury; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Liver Function Tests; Male; Middle Aged; Pravastatin; Simvastatin | 2000 |
Myositis, microvesicular hepatitis, and progression to cirrhosis from troglitazone added to simvastatin.
Topics: Aged; Anticholesteremic Agents; Antioxidants; Chemical and Drug Induced Liver Injury; Chromans; Diabetes Mellitus, Type 2; Disease Progression; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Hypoglycemic Agents; Liver Cirrhosis; Myositis; Simvastatin; Thiazoles; Thiazolidinediones; Troglitazone | 2001 |
Simvastatin-diltiazem drug interaction resulting in rhabdomyolysis and hepatitis.
Topics: Calcium Channel Blockers; Chemical and Drug Induced Liver Injury; Diltiazem; Drug Interactions; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Rhabdomyolysis; Simvastatin | 2001 |
[Simvastatin-induced hepatitis].
Topics: Anticholesteremic Agents; Chemical and Drug Induced Liver Injury; Humans; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Simvastatin | 1992 |
Acute cholestatic hepatitis during simvastatin administration.
Topics: Acute Disease; Anticholesteremic Agents; Chemical and Drug Induced Liver Injury; Cholestasis; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver; Lovastatin; Middle Aged; Simvastatin | 1991 |
Pravastatin and simvastatin for hypercholesterolemia.
Topics: Anticholesteremic Agents; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Drug Therapy, Combination; Heptanoic Acids; Humans; Hypercholesterolemia; Lovastatin; Muscular Diseases; Naphthalenes; Pravastatin; Simvastatin | 1991 |
[A case of hepatitis caused by simvastatin].
Topics: Anticholesteremic Agents; Chemical and Drug Induced Liver Injury; Humans; Lovastatin; Male; Middle Aged; Simvastatin | 1991 |